NIH Funding Opportunities (Notices, PA, RFA)

Subscribe to NIH Funding Opportunities (Notices, PA, RFA) feed
Weekly Funding Opportunities and Policy Notices from the National Institutes of Health.
Updated: 1 hour 13 min ago

Identifying Innovative Mechanisms or Interventions that Target Multimorbidity and Its Consequences (R01 Clinical Trial Optional)

Thu, 2020-04-30 02:14
Funding Opportunity PAR-20-180 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications that seek to support the identification of shared mechanisms and development of innovative interventions to address multimorbidity (or multiple chronic conditions (MCCs)) and its consequences. Intervention research supported by this initiative should be designed to study: (1) mechanisms or pathways that prevent MCCs, including the identification of early biomarkers, behavioral pathways, and individual and contextual risk factors and interactions that contribute to the development of common MCCs; (2) targeted therapies and management, including self-management, of MCCs to delay progression and prevent onset of new diseases; and (3) innovative health care partnership models for managing or treating MCCs. Studies may include shared mechanisms, and assessments of interactions between risk factors and interventions that address MCCs at different periods of the lifespan in diverse populations. Use of innovative technologies to assess and intervene on risk factors and pathways are encouraged. Studies may also include those that make use of existing data and/or data linkages to explore new research questions that may be helpful in understanding the impact of mechanisms in isolation or in combination. Of particular interest are interventions that target prevention and treatment of multiple chronic health conditions, including study designs that address therapeutic targets for preventing co-occurring multiple chronic conditions. Prospective applicants whose research interests relate to developing improved measures and methods for understanding multimorbidity, including but not limited to measures/tools to support basic mechanistic discovery of shared MCC pathways and identification and initial evaluation of MCC shared signatures, should see PAR-XX-XXX.

U.S. - India Collaborative Environmental Health Research Program (R01 Clinical Trial Optional)

Wed, 2020-04-29 04:58
Funding Opportunity RFA-ES-20-010 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement is to promote collaborative research among US and Indian scientists in the field of environmental health research with a focus on air pollution.

Competitive Revision Supplements to Existing AHRQ Patient Centered Outcomes Research (PCOR) Grants and Cooperative Agreements to Evaluate Health System and Healthcare Professional Responsiveness to COVID-19 (Supplement - Clinical Trial Optional)

Wed, 2020-04-29 04:23
Funding Opportunity PA-20-072 from the NIH Guide for Grants and Contracts. The Agency for Healthcare Research and Quality (AHRQ) hereby notifies grantees holding active AHRQ awards that were funded under the PCOR FOAs, (see referenced FOAs under: Part 1. Overview Information, Activity Code), that funds are available for competitive revisions to meet immediate needs to help address timely health system and healthcare professional response to the COVID-19 public health crisis. This FOA does not include grants that were awarded using AHRQ Health Service Research (HSR) dollars (please see FOA number PA-20-070, which is directed toward those grants). It is expected that competitive revision supplement requests will capitalize on the expertise of grant personnel and the institutional environment to expand the specific aims of the on-going research to develop high-impact new knowledge concerning COVID-19. The proposed projects must support dissemination of comparative clinical effectiveness research findings or the training of researchers in the methods used to conduct such research. Funding will be available in Fiscal Year 2020.

Competitive Revision Supplements to Existing AHRQ Health Service Research (HSR) Grants and Cooperative Agreements to Evaluate Health System and Healthcare Professional Responsiveness to COVID-19 (Supplement - Clinical Trial Optional)

Wed, 2020-04-29 04:23
Funding Opportunity PA-20-070 from the NIH Guide for Grants and Contracts. The Agency for Healthcare Research and Quality (AHRQ) hereby notifies grantees holding active AHRQ awards, (except R13s, T32s, F32s), that funds are available for competitive revisions to meet immediate needs to help address timely health system and healthcare professional response to the COVID-19 public health crisis. This FOA does not include grants that were previously funded under FOAs supported by Patient Centered Outcome Research Trust Fund (PCOR TF) dollars (Please see FOA number PA-20-072, which is directed towards those grants).

Notice of Special Interest (NOSI): Heart, lung, blood and sleep focused ancillary studies to large ongoing clinical trials

Wed, 2020-04-29 03:22
Notice NOT-HL-20-755 from the NIH Guide for Grants and Contracts

Notice to Extend the Expiration Date for PAR-17-465 "Bench Testing Therapeutic/Indication Pairing Strategies (UG3/UH3)"

Tue, 2020-04-28 13:41
Notice NOT-TR-20-025 from the NIH Guide for Grants and Contracts

Notice to Extend the Expiration Date for PAR-17-170 "Alcohol Research Resource Awards (R24)"

Mon, 2020-04-27 12:55
Notice NOT-AA-20-012 from the NIH Guide for Grants and Contracts

Request for Information: Soliciting Input for the National Center for Complementary and Integrative Healths New Strategic Plan

Mon, 2020-04-27 12:41
Notice NOT-AT-20-013 from the NIH Guide for Grants and Contracts

Pages